The Leadership Team at Adrestia Therapeutics is responsible for driving the company's strategic vision and innovation in synthetic rescue therapies. This team, comprised of experienced executives in research, operations, human genetics, and business development, collaborates to advance the understanding of genetic networks and oversee the development of groundbreaking treatments, ensuring the company's growth and impact in the biotechnology sector.
Dr. Yaron Galanty
Co-Founder and VP research/ He...
GABRIEL BALMUS
Co-Founder
Jane Whitrow
Interim Chief Operations Offic...
Jennifer Millian
Vice President US Operations
John Perry
Vice President of Human Geneti...
Katherine Ewings
Vice President Biology
Philip Coxon
Vice President of Business Dev...
Rafael E. Carazo Sal...
Co-Founder and Consultant
Robert Johnson
Chief Executive Officer
Tom Heightman
Chief R&D Officer
View all